glp-1 drug news today 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Market Trends and Global

But it wasnt until semaglutide hit the market (first as Ozempic [archived link] in 2017 followed by Wegovy [archived link]) in 2021) that GLP-1 RAs captured the worlds attention

The observational study, led by Elizabeth McDonald, MD, PhD, a professor of radiology at the University of Pennsylvania Perelman School of Medicine, shows a correlation between GLP-1 use and reduced breast cancer incidence

Kobayashi K, Toyoda M, Tone A, et al

Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity

For medical coders, success depends on accurate diagnosis selection, payer policy knowledge, prior authorization tracking, and airtight documentation

Gastroparesis is a chronic disorder that is commonly comorbid with Ehlers Danlos Syndrome, and involves delayed stomach emptying without a blockage